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1. BACKGROUND, HYPOTHESIS AND AIMS 
Functional gastrointestinal (GI) disorders can be defined as a variable combination of 
chronic or recurrent GI symptoms not explained by any structural alterations [1]. Although 
such functional disorders are not life-threatening, they affect a significant proportion of the 
population, and account for a large number of those patients seeking either primary care or the 
gastroenterology specialist. The estimated frequency of functional biliary diseases is much 
lower. A recent large survey, based only on symptomatic criteria, suggested that the 
frequency of functional biliary pain in the general population was 1.5%. Biliary pain was 
associated with complaints which were more persistent and gave rise to a significantly higher 
rate of physician visits than for patients with other functional GI disorders. Functional biliary 
pain presented with a female predominance, the female/male ratio being approximately 4:1, 
and with an increased prevalence in the age group over 45 years [2]. Functional biliary pain 
can be defined as repetitive episodes of moderate to severe abdominal pain recurring over a 
minimum of 3 months, located in the epigastrium and/or right upper quadrant (RUQ), and 
persisting for a minimum of 20 min [VII, VIII]. Biliary pain may be associated with nausea or 
vomiting, the onset coming after meals with typical radiation into the back and/or right 
subscapular region. Theoretically, biliary pain can be evoked by the biliary tract distension 
caused by an impaired bile outflow, ischaemia arising from spastic smooth muscle 
contractions and hypersensitivity of pain sensory nerve endings around the gallbladder (GB), 
the sphincter of Oddi (SO) or the common bile duct (CBD) (3). Oddi initially suggested that 
biliary pain and jaundice could be caused by a functional spasm of the SO [4]. Later, 
Zollinger and Cutler documented that distension of the GB or the CBD triggered deep 
epigastric and/or RUQ pain [5]. Interestingly, biliary pain was more frequently located in the 
epigastrium and, as compared to the GB, distension of the CBD was accompanied by more 
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severe pain, nausea and vomiting [5]. It is important to emphasize the problem of 
distinguishing hepatobiliary pain from that originating from organs such as the oesophagus, 
the stomach, the small and large bowel, the pancreas and the coronary arteries [6]. Organic 
and functional extrabiliary disorders may also evoke upper abdominal pain with a similar 
location and characteristics. Furthermore, balloon distension at different points of the gut, 
such as rectal and duodenal distension, may induce abdominal pain at unpredictable sites 
throughout the abdomen, as demonstrated in patients with irritable bowel syndrome [7]. It is 
therefore obvious that, if differentiation is based only on the patient symptoms, a precise 
distinction between abdominal pain of biliary and non-biliary origin is hardly possible. Quite 
clearly, objective diagnostic methods are needed for the diagnosis of functional disorders of 
the biliary tract [IX, X]. 
A short description of the physiological background of biliary motility is essential for 
an understanding of functional biliary pain syndromes [XI]. The biliary tract plays an 
essential role in the discharge of bile into the duodenum. The two major compartments that 
actively control the bile flow are the GB and the SO. Hepatic secretion and GB contraction 
are the main driving forces of bile flow. The direction of the bile flow and the partition of the 
secreted bile within the biliary tract are determined by the relative resistances of the cystic 
duct and the SO. The SO represents a zone with a higher basal (resting) pressure (BP) than the 
duodenal or the CBD pressure with superimposed phasic activity. Filling of the GB occurs 
when a negative pressure gradient develops across the cystic duct due to simultaneous SO 
contraction and GB relaxation. During fasting, the GB stores and concentrates the secreted 
hepatic bile. Food intake simultaneously inhibits the SO basal tone and phasic activity, and 
facilitates GB contraction [3], This motility pattern of the GB and the SO is controlled by 
complex humoral and neural mechanisms [XI]. The physiological effects of cholecystokinin 
(CCK) are postprandial contraction of the GB and relaxation of the SO. CCK acts directly on 
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CCK-A receptors in the muscle coat of the GB and evokes a dose-dependent contraction on 
the GB; in contrast CCK is a potent inhibitor of the SO basal and phasic activity. The release 
of CCK after food intake is the most important factor in the inhibition of the SO in the 
postprandial period, allowing an increased bile flow in consequence of the simultaneous GB 
contraction across the SO with decreased resistance. The CCK-induced GB contraction can be 
partially inhibited by atropine, suggesting that CCK-stimulated acetylcholine release may also 
contribute to the direct GB-contracting effect of CCK. Theoretically, either hypersensitivity of 
the GB or hyposensitivity of the SO to CCK might cause an acalculous biliary colic when the 
GB is contracting against a partially closed SO. The inhibitory effect on the SO of CCK after 
intravenous administration lasts for 2-6 min, and the SO activity subsequently returns to 
normal [8]. The mechanism of this dominant inhibitory action of CCK on the human SO 
appears to be mediated by stimulation of the CCK receptors on the non-adrenergic non-
cholinergic (NANC) inhibitory neurones in the intramural ganglions. This NANC receptor 
stimulation involves the release of direct smooth muscle relaxants, such as nitric oxide. (NO) 
and/or vasoactive intestinal polypeptide (VIP). The latter effect overrides the direct smooth 
muscle-stimulatory effect of CCK on the SO [9]. Theoretically, an imbalance between the 
dominant inhibitory effect and the direct smooth muscle-excitatory action of CCK on the SO 
(called the denervation pattern, since it may be due to the loss of inhibitory neurones) could 
lead to an inappropriate spasm, referred to as the paradoxical response of the SO after CCK 
administration [10]. Although this paradoxical response of the SO (including the reproduction 
of biliary pain) evoked by high-dose CCK administration has been demonstrated by 
endoscopic SO manometry (ESOM) in a few patients with a SO dysfunction (SOD) [10], 
there are no convincing human immunohistochemical data relating to the loss of inhibitory 
neurones in patients with functional biliary disorders [11]. 
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In addition to CCK and VIP, gastrin, secretin, glucagon, methionine enkephalin and 
substance P are also able to relax the SO, but, with the exception of substance P, they are less 
potent than CCK [XI]. Other GI peptides and their analogues, such as pentagastrin, motilin, 
morphine, somatostatin and pancreatic polypeptide can stimulate the SO and inhibit bile flow 
across the sphincter. Motilin is believed to be a major humoral component influencing the 
interdigestive GB motility, resulting in periodic GB contraction in conjunction with the 
migrating myoelectrical activity of the duodenum. Cholinergic and muscarinergic stimulation 
increases the resistance of the SO, while in contrast nicotinic agonists induce SO relaxation. 
Specific pharmacological stimulation of adrenergic alpha-receptors increases the SO tone 
while beta-adrenergic stimulants diminish it. It is currently believed that the autonomic 
nervous system do not exert a major influence on the SO contractile activity, but appear to set 
the background tone, which is then modulated by the enteric nervous system, GI hormones 
and peptides. Furthermore, studies on humans and experimental animals have demonstrated 
neuronal connections between the proximal bile ducts, the GB and the SO. These connections 
take part in a reflex relaxation of the SO following distension of the GB and proximal bile 
ducts. Interruption of the reflex inhibitory pathways between the SO and the GB as a result of 
cholecystectomy might also contribute to the frequent generation of functional disorders after 
cholecystectomy [12,13]. 
Functional disorders of the biliary tract can be classified as a GB dysfunction and a 
SOD [XII]. In clinical practice, it is often difficult to localize the anatomical site of the 
abnormality and to differentiate purely functional conditions from imperceptible structural 
changes. This is particularly true for the biliary tract, where the implementation of any direct 
measuring device is difficult, and the interpretation of minor histological abnormalities is not 
well standardized, so that in many instances any functional and structural abnormalities may 
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therefore merge [14]. Consequently, the development of objective diagnostic methods for 
differentiation between functional and structural disorders is of great importance. 
The characteristic features of a GB dysfunction are acalculous biliary pain (ABP) and 
abnormal GB motility [XI]. Decreased contraction (GB hypokinesia), excessive contraction 
(GB hyperkinesia) and dyscoordinated contraction (GB dyskinesia) have been postulated to 
cause biliary pain. The mechanism of GB hypokinesia due to underlying primary disorders is 
well described, but the pathogenesis of GB dyskinesia is often confused with cystic duct 
syndrome, and is poorly understood. GB hypokinesia, which is a primary defect of the GB 
contraction, may be caused by either an impaired smooth muscle function and/or defective 
neuroendocrine mechanisms. GB hypokinesia may be induced by a number of organic 
disorders, such as chronic cholecystitis, cirrhosis, diabetes or somatostatinoma, and can be 
secondary to impaired endogenous CCK release due to Billroth II gastric resection, vagotomy 
and celiac disease. However, it is problematic to speculate on how defective smooth muscle 
contractility could induce biliaiy pain. Hence, attempts have been made to explain the 
mechanism of ABP by an exaggerated GB contraction, which was intended to overcome a 
partial cystic duct obstruction. The term "cystic duct syndrome" was originally proposed by 
Cozzolino et al. to describe this clinical condition [15], in which the cystic duct obstruction is 
interpreted to be due to a stone, inflammation or stricture. Nevertheless, it has been speculated 
that the clinical syndrome of GB dyskinesia might be due to a pure motility disorder, caused 
by a lack of coordination between the GB and the cystic duct, i.e. a cystic duct spasm, which 
can produce an increased resistance at the level of the cystic duct at the time of GB 
contraction [XI, XII]. The concomitant occurrence of biliary pain and impaired GB emptying 
is more easily understood, as the GB is attempting to empty its contents against an increased 
cystic duct resistance. The biliary pain might originate from the pressure rise due to the GB 
contraction against the increased cystic duct resistance. This logical pathogenic mechanism of 
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GB dyskinesia originally suggested by Toouli ten years ago, however, there are no human 
data as to support this hypothesis yet [16]. 
SOD can be defined as a functional disturbance of the SO with clinical signs of biliary 
or pancreatic disorders. Episodes of moderate to severe steady pain located in the epigastrium 
or the RUQ, recurring more often than every 3 months, are the most common presenting 
symptoms in patients subsequently shown to have SOD. Pain is more commonly manifested 
in cholecystectomized patients and leads to the development of postcholecystectomy 
syndrome [XI, XII]. It has been estimated that SOD occurs in around 1% of patients 
undergoing cholecystectomy, and in about 14% to 28% of those having postcholecystectomy 
pain syndrome [17, 18]. The clinical suspicion is supported by a transient elevation of the 
levels of liver enzymes such as alkaline phosphatase or aspartate aminotransferase (AST) 
and/or a dilated CBD in an absence of any obvious structural alterations. Endoscopic 
retrograde cholangiopancreatography (ERCP) plays a major role in the diagnostic evaluation 
of patients with SOD by the exclusion of structural disorders. The diagnostic 
cholangiographic criteria for SOD include a dilated CBD (>12 mm) and a delayed contrast 
drainage time (> 45 min). It has been suggested that these patients with SOD should be 
subdivided into three groups on the basis of the results of laboratory tests and the ERCP 
findings. SOD biliary group I patients present with abdominal pain, abnormally elevated liver 
enzymes, a dilated CBD and a delayed contrast drainage time. SOD biliary group II patients 
have abdominal pain and at least one of the previously mentioned criteria. In the patients in 
SOD biliary group III, the abdominal pain is not accompanied by other objective criteria [19]. 
Toouli et al. applied the pathogenic mechanism for a simplified categorization of SOD 
patients into two subgroups: with SO stenosis or with SO dyskinesia [16]. SO stenosis is a 
structural narrowing of the SO, which may be caused by inflammation, fibrosis, smooth 
muscle hypertrophy or adenomyomatosis, while SO dyskinesia is a purely functional 
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disturbance of the SO [20, 21]. It has been demonstrated that most patients with SO 
dyskinesia (i.e. the functional group) display no objective diagnostic abnormality on ERCP 
and most of them can therefore be categorized into biliary groups II and III of SOD [20, 21]. 
The introduction of ESOM into clinical practice can be regarded as a major step both in the 
exploration of the physiologic motor function of the human SO and in the diagnosis of 
motility disorders in patients with SOD [22, 23]. In patients with SOD, several motility 
abnormalities have been described, such as a constantly elevated BP, short periods of raised 
BP (spasm or dys-coordination), increased amplitude of phasic contractions (PCs), the 
frequent occurrence of retrograde propagation of PCs, a higher frequency of PCs 
(tachyoddia), and a paradoxical response to CCK administration [24, 25]. 
Interestingly, GB dysfunction and SOD may co-exist in the same patient, and their 
pathogenic mechanism may therefore be related to each other, as suggested by follow-up 
studies [26]. Manometric abnormalities of the SO were demonstrated not only in 
cholecystectomized patients, but also in those with an intact GB. This finding strongly 
supports the evidence that SOD may exist before cholecystectomy [26]. Removal of the GB in 
these patients results in a high probability of the development of biliary pain through loss of 
the reservoir and pressure equalizing functions of the GB, the previously compensated 
abnormality thereby being unmasked [27]. 
The reported frequencies of abnormal ESOM in postcholecystectomy patients in SOD 
biliary groups I, II and III were 85.7%, 55.1% and 28.1% respectively [19]. These findings 
strongly suggest that, in a significant number of postcholecystectomy patients with SOD III, 
either the motility of the SO is normal or the motility abnormalities are unrelated to the 
symptoms [28]. Thus, as in other fields of gastroenterology, the hypothesis of abnormal 
responses to physiological stimuli (i.e. hyperreactivity) or abnormal perception of normal 
events (i.e. hypersensitivity) must be emphasized in connection with the possible pathogenic 
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mechanism of functional biliary pain [29]. This seemingly new concept was already 
mentioned in a review by Varro and Lonovics in 1988 [30]. They suggested that, at an early 
stage of the disease, the hypersensitive SO responds to various physiological stimuli with 
spasm (hyperreactivity) and/or typical biliary pain (hypersensitivity), whereas an elevated SO 
pressure and signs of biliary outflow obstruction (dysmotility) mainly occurred during 
provocation periods (pure hypertonic SO dyskinesia). In a later stage, a partial SO stenosis 
may develop, with an intermittently elevated SO BP, but the SO is still able to relax after the 
administration of smooth muscle relaxants such as amyl nitrite (AN) and glyceryl trinitrate 
(GTN), or to contract during provocation tests (mixed hypertonic SO dyskinesia). Eventually, 
organic stenosis and biliary obstruction with a constantly elevated SO pressure unequivocally 
develop (stenosis of the SO). Several indirect lines of evidence suggest a possible 
involvement of hypersensitivity or hyperalgesia in the pathogenesis of functional biliary pain, 
but this concept has still not been generally accepted [29]. Central sensitization i.e. 
hyperactivity of the central nervous system due to long-term nociceptive peripheral stimuli, 
might have a pathogenic role in the development of postcholecystectomy pain syndrome. The 
latter may be supported by the fact that the duration of the symptomatic history before 
cholecystectomy has been strongly correlated with the poor symptomatic outcome after 
cholecystectomy, as demonstrated 30 years ago in the excellent study by Bodvall and 
Overgaard [31]. Central sensitization leads to site-selective visceral hypersensitivity, which 
means a lower threshold to symptomatic recognition and pain perception as well. These 
mechanisms are also modulated by spinal and cortical stimuli, consequently, psychic 
vulnerability might be able to influence the development of biliary pain [32]. Lasson et al. 
demonstrated that up to 34% of patients with postcholecystectomy pain and normal ERCP 
experienced severe pain at the time of contrast injection [33]. In some patients with SO 
dyskinesia, cannulation of the papilla of Vater itself was painful, this condition was therefore 
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called "tender papilla". However, these studies were criticized for the lack of a correlation 
between the occurrence of biliary hypersensitivity during ERCP and the presence of SO 
motility disturbances with ESOM [34]. Hyperreactivity of the SO is another possible 
pathogenic mechanism of postcholecystectomy biliary pain and SO dyskinesia. Provocation 
tests have traditionally been used in the diagnosis of SO dyskinesia. Most of these 
provocation tests are based on morphine sulphate (MS) administration [35]. MS has a 
physiological stimulatory effect on the human SO. Very low doses of MS (2.5 pg/kg) increase 
the frequency and the amplitude of PCs, whereas higher doses can cause an SO spasm with a 
substantial elevation of the SO BP [36]. The effect of MS can be antagonized by naloxone, 
but not by atropine [37]. This phenomenon suggests a direct smooth muscle-stimulatory effect 
of MS by facilitating the Ca2+ influx through the voltage-dependent or receptor-operated 
calcium channels. In patients with SO dyskinesia, a marked rise in CBD pressure was 
demonstrated by means of ESOM during MS administration, which was associated with 
biliary pain [38]. Provocation tests based on MS administration, such as the Debray and the 
Nardi test, have been suggested in the diagnostic evaluation of patients with SOD [39, 40], 
but the usefulness of these tests has been criticized because of their relatively low specificity 
and sensitivity as compared with the results of ESOM [41]. In fact, biliary pain and the CBD 
pressure elevation after MS administration could be demonstrated by means of intraoperative 
manometry in a large percentage of patients with SO dyskinesia [42]. The frequencies of SO 
dysmotility demonstrated by ESOM were significantly higher in patients who gave a positive 
Nardi provocation test [43, 44]. The usefulness of these provocation tests was strongly 
supported by the fact that clinical and symptomatic improvements occurred after endoscopic 
sphincterotomy (EST) in a high percentage of those patients in whom the provocative tests 
were positive [45]. These findings make it probable that, in a number of patients with SO 
dyskinesia, hypersensitivity and hyperreactivity of the SO might be an essential pathogenic 
mechanism [45], as initially suggested by Varró and Lonovics [30]. 
Despite many advances in the management of biliary tract diseases, the diagnosis of 
functional disorders remains a challenge. Recent advances in radiology, such as computed 
tomography, endoscopic ultrasonography and magnetic resonance imaging, have not resulted 
in real progress in this field, because of a lack of morphological alterations in this group of 
patients. The diagnosis must therefore be based on functional testing, such as provocation 
tests, hepatobiliary scintigraphy and ESOM. However, the ideal method has not yet emerged, 
and a number of controversies are still unsolved. 
ESOM is considered to be the best method currently available in the diagnosis of SOD 
[46], but several problems can arise in the performance and interpretation of biliary 
manometry. The procedure itself is expensive, with special requirements as concerns the 
technical background and medical knowledge. Therefore, it can be performed only in a few 
specialized centres. ESOM is an invasive procedure that allows only minimal premedication 
and consequently is difficult to carry out and is often inconvenient to the patient. Even an 
experienced endoscopist could perform an adequate and complete examination in only 54-
87% of the patients [47]. There are inherent technical problems with ESOM itself, since a 
relatively large tube is placed into a small orifice of a narrow channel, which is then perfused 
with water. Conclusively, after the mechanical insult to the papilla of Vater due to the 
cannulation, there is an obstruction of the biliary system during the measurement, making this 
procedure non-physiological. Furthermore, the frequent occurrence of several manometric 
artefacts often makes the interpretation problematic. The difficulties in the correct 
performance and interpretation of ESOM studies may influence intra- and interobserver 
variability [48]. Methodological variations in catheter and infusion systems, as well as 
variations in the condition of the patient, may also exert critical effects on the results of 
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ESOM. The SO pressure profile may also depend on the duodenal contractions, and the cyclic 
phases of the duodenal migrating motor complex at the time of ESOM [49, 50]. Furthermore, 
possible misinterpretation of the tracings due to the manometric artefacts, such as initial 
hyperactivity, catheter movement and hyperventilation, can be a real problem [3]. 
Unfortunately, with the progress in the clinical applications of ESOM, it has become obvious 
that it is associated with a higher incidence of procedure-related pancreatitis, as compared to 
simple diagnostic ERCP [51, 52]. The incidence of post-ESOM pancreatitis is reported to 
vary from 8% to 31%, depending on the length of the investigation, the rate of manometric 
catheter perfusion and whether the biliary or pancreatic segment of the SO is evaluated. 
Although a reduction of post-ESOM pancreatitis from 31% to 4% was reported when one 
lumen of the manometric catheter was used for continuous aspiration, it is still a significant 
risk for those patients having only functional GI disorders [53]. These problems may facilitate 
the clinical strategy by not troubling with ESOM at all, but by going ahead and performing 
EST in all patients with suspected SOD. Unfortunately, this is not a favourable approach 
either, because the risk of EST-induced complications, such as pancreatitis, bleeding and 
perforation, is significantly higher in patients with SOD and non-dilated bile ducts (functional 
group, biliary type III) than in patients with other indications [54, 55]. It is unacceptable to 
induce a serious complication in a subject who perhaps has no biliary disease. Furthermore, it 
is estimated that if ESOM is applied to screen patients with postcholecystectomy syndrome, 
more than four examinations are required for all cases of SOD with elevated BP to be 
detected. This efficacy ratio is intolerable for an invasive procedure that is both difficult to 
perform and associated with potentially dangerous complications in patients with a functional 
disease. 
A widely available, non-invasive screening method is therefore required for the 
diagnosis of SOD. From this respect, hepatobiliary scintigraphy is an ideal substitute for 
ESOM: it can be performed with a low radiation exposure and without any procedure-related 
complications. The radiation dose during hepatobiliary scintigraphy is approximately 3 mSv 
in effective dose equivalent, which is equal to an annual background radiation dose. Although 
hepatobiliary scintigraphy was originally suggested as a promising method for the diagnosis 
of SOD, several controversies have led to its acceptance as an alternative diagnostic test in 
patients with suspected SOD that is progressing rather slowly. It has been claimed that, 
although hepatobiliary scintigraphy may be used as a method for the detection of a low-grade 
biliary obstruction in patients with SO stenosis [56, 57], it is not sensitive enough to be a 
definitive screening test in patients with SO dyskinesia. It has been documented that a 
significant overlap may exist between the results of hepatobiliary scintigraphy on the normal 
population, asymptomatic cholecystectomized patients, patients with cholestasis due to 
hepatocellular disease, and patients with SOD [58, 59]. Another criticism of hepatobiliary 
scintigraphy is that it is not able to differentiate between patients with organic (SO stenosis) 
and functional (SO dyskinesia) disorders [60]. 
To summarize the current status, on the one hand we are dealing with a number of 
patients who have a biliary pain syndrome without any obvious explanation, while on the 
other hand the available functional diagnostic methods with which these patients might be 
investigated have obvious shortcomings. The present work has the aims of further elaboration 
of these problems and the provision of new prospects in the diagnosis of functional biliary 
disorders. The main goals were to make the available tests more objective; to select the most 
sensitive scintigraphic parameters with quantification; to validate hepatobiliary scintigraphy 
as a possible alternative for invasive manometry; to reinforce the value of provocation or 
pharmacological tests in the diagnosis of functional biliary disorders; to develop new methods 
that can be applied in the differentiation of organic and functional abnormalities; and to 
improve the diagnostic efficacy in patients with functional biliary disorders. 
13 
2. METHODS 
2.1. QUANTITATIVE HEPATOBILIARY SCINTIGRAPHY 
Hepatobiliary scintigraphy is a simple, widely available, non-invasive isotope 
diagnostic method with which to investigate the function of the hepatobiliary system. It can be 
accomplished with a low radiation exposure with the use of 99mTc agents. 
Radiopharmaceuticals such as 99mTc-N-2,6-dimethylphenylcarbamoylmethyl-iminodiacetic 
acid (99mTc-EHIDA) and a variety of its analogues, such as 99mTc-N-2,6-diisopropyl-
iminodiacetic acid (DISIDA) and 99mTc-2,4,6-trimethyl-3-bromo-iminodiacetic acid 
(mebrofenin) can be used for hepatobiliary imaging [61]. With the clinical application of 
hepatobiliary scintigraphy, it is possible not only to detect a biliary obstruction, but also to 
determine the hepatic cell function via the rate of bile secretion and to investigate the GB and 
SO motility by following the course of bile emptying [62, 63]. After their i.v. injection, these 
99mTc agents bind loosely to serum proteins; subsequently, about 98% of the injected dose is 
taken up by the hepatocytes and rapidly secreted unaltered into the bile without further 
metabolism. This uptake mechanism proceeds in parallel to that of bilirubin, and 
hyperbilirubinaemia therefore has a competitive inhibitory effect. After excretion by the 
hepatocytes, the bile continues to flow from the bile canaliculi through the canals of Hering to 
the major intrahepatic bile ducts and the CBD, and then empties into the GB and the 
duodenum. Normally, almost 70% of the radioactivity secreted by the liver enters the GB 
during fasting, giving excellent conditions for imaging and quantification. After the hepatic 
excretion, the bile flow is predominantly a passive process, determined by the least resistance 
and pressure. Pressure changes inside the extrahepatic bile ducts and the GB therefore exert a 
critical influence on the isotope emptying. 
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The methodology of hepatobiliary scintigraphy is simple, but should be followed 
precisely in every patient to achieve optimal results and comparability [IX, X]. Patients 
should be fasted for a minimum of 4 hours prior to the investigation. The gamma-camera is 
positioned over the right upper abdomen of the supine patient. After an i.v. bolus injection of 
5 mCi (140 MBq) 99mTc-EHIDA, gamma-camera images are acquired. Analogue images 
should be obtained every 10 min for the first hour, with delayed images if required (first 
image acquisition for 500 000 counts, and subsequent images for the same length of time). 
The analogue pictures should be examined for liver radiotracer uptake, size, shape and 
homogeneity. The liver uptake of 99mTc-EHIDA is rapid, with scarcely any tracer left in the 
blood by the 5th min. In most normal fasting subjects, radioactivity appears in the GB and in 
the small bowel by 1 hour after its administration. The extent of visualization of the hepatic 
ducts is variable, but the left duct tends to be more prominent than the right. Excretion of 
radioactivity into the duodenum occurs by 60 min in 81% of patients with an intact GB. In the 
remaining 19% of patients without bowel activity at 60 min, duodenal visualization may be 
achieved after exogenous CCK administration. This failure to visualize the small bowel by 1 
hour in a small proportion of normal fasting subjects is thought to be attributable to a 
physiologically tight SO during the GB filling period [64]. After cholecystectomy, the bile 
flow from the bile ducts into the duodenum can be described by a simple two-compartment 
model, and it is therefore less variable. In cholecystectomized patients without extra-hepatic 
bile duct obstruction, the level of radioactivity of the CBD reaches its maximum before 45 
min, and the amount of radioactivity in the bile ducts afterwards decreases, with rapid 
emptying into the duodenum (Figure 1\ 
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hepatobiliary scintigraphy recording in a 
cholecystectomized patient with a normal liver size, a normal hepatic uptake of the 
radioactivity, with rapid excretion into the bile ducts, and obviously free transpupillary 
bile flow, without signs of extrahepatic biliary obstruction. 
Analysis of the hepatic bile secretion and biliary flow characteristics on the basis of 
planar images alone involves the risk of an interpretation bias. To exclude this shortcoming of 
the original method, therefore, quantitative hepatobiliary scintigraphy (QHBS) was introduced 
into clinical practice [XIII, XIV], Computer-assisted quantitative analysis of the time-activity 
curves (TACs) constructed from regions of interests (ROIs) led to an improvement in the 
diagnostic accuracy of hepatobiliary scintigraphy [63, 64], After administration of the tracer, 
digital images should be obtained consecutively at one frame/min for 90 min, and computer-
recorded in a 64x64 matrix. During the analysis, ROIs should first be selected over the right 
peripheral liver parenchyma (LP), hepatic hilum (HH), CBD and duodenum. TACs are then 




Figure 1. Representative 
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parameters, such as the time to peak activity (Tmax), the half-time of excretion (T1/2), the 
hilum-to-duodenum transit time (HDTT), the duodenum appearance time (DAT) and the 
accumulation ratio (AR). AR is a quotient, which can be calculated as T1/2 for the CBD 
divided by T1/2 for of the LP (Figure 2). 
Figure 2. Schematic presentation of the method of calculation of QHBS 
parameters from the time-activity curves (Tmax: maximal activity, Ti/2: half-time of 
excretion, DAT: duodenal appearance time, HDTT: hilum-duodenum transit time). 
The applicability of hepatobiliary scintigraphy for quantification is extremely useful 
because it allows numerical measurement of the bile secretion and flow. These values can be 
utilized to compare different groups of patients, to perform follow-up studies in a given 
patient group and to monitor the efficacy of specific therapeutic interventions. In patients with 
normal bile secretion and free trans-papillary bile flow, the TACs have a typical exponential 
shape during the emptying phase (Figure 3). Quantification of hepatobiliary scintigraphy 
allows the detection of minor bile flow disturbances, which frequently occur in patients with 
functional SO dyskinesia. 
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Figure 3. Representative recording of the final results of QHBS in a 
cholecystectomized patient with normal bile secretion and emptying. The upper panel 
depicts parametric and cumulative pictures with ROI selection, while the lower panel 
demonstrates TACs of the LP (white), HH (red), CBD (yellow) and duodenum (pink). 
QHBS is a valuable method for differentiation between primary cholestatic liver 
diseases and extrahepatic biliary obstruction. In patients with intrahepatic cholestasis, there is 
a primary increase in T1/2 over the LP (slower hepatic secretion), which then determines the 
slower emptying (T1/2) of the HH and CBD. However, in patients with an extrahepatic biliary 
obstruction, T1/2 over the LP is usually normal, but becomes abnormal over the HH, and 
reaches its maximum over the CBD [XIII]. 
The GB function can be optimally determined by the application of QHBS during the 
GB phase imaging [65]. These data can preferably be acquired in a separate 30-min study 
between 60 to 90 min after the administration of 99mTc-EHIDA. If there was any overlap of 
the CBD and GB radioactivity during the hepatic phase imaging, an attempt should be made 
Y ' f«V\ 
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to separate them by changing the angle of the gamma-camera. Superimposed duodenal 
activity can be cleared if the patient drinks a glass of water. The GB emptying after 
consumption of a test meal or administration of exogenous CCK may be measured 
numerically by means of QHBS, which is a reliable test for assessment of the GB function. 
QHBS combined with administration of a fatty meal or an exogenous CCK analogue is a 
validated and accurate method for measurement of the ejection fraction (EF) of the GB, with 
satisfactory reproducibility of both parametric variables and emptying patterns [66]. The 
intra- and interobserver variability of endogenous CCK release after administration of a fatty 
meal made this stimulation test somewhat unfavourable for GB EF determination. This 
variability is not only due to the different CCK receptor count and activity in the upper GI 
tract, but is also induced by the high interindividual variability of gastric emptying after a 
caloric meal. Most of the investigators therefore apply exogenous CCK administration to 
evoke GB contraction. These data can be acquired into the computer separately at one 
frame/min, 60 min after the initial isotope administration, as a GB phase imaging study. The 
ROIs should first be placed over the GB and over the liver parenchyma adjacent to the GB. 
After a background correction, a GB TAC is generated, and the GB EF is then calculated by 
using the equation EF%=(GBmax-GBmin)/GBmax x 100. The degree of GB emptying is CCK 
dose-dependent, and the manner of CCK administration therefore has a critical effect on the 
overall GB contraction. The GB EF increases linearly as the dose of CCK is increased from 
0.5 to 3.3 ng/bwkg/min, with a subsequent decrease when larger doses are infused, especially 
when CCK is given as a rapid i.v. bolus [51]. The effects of small infused doses of CCK 
(under 0.5 ng/bwkg/min) on GB contraction are quite variable. Additionally, a 
supraphysiological dose of CCK produces a low GB EF too in association with abdominal 
pain, even in normal subjects. This is probably due to a cystic duct contraction, and should 
therefore be avoided. The normal GB EF value is 35% or higher, based on 3.3 ng/body weight 
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kg/min CCK infusion administered for a minimum of 3 min, and can be regarded as an 
indicator of a normal GB motor function [65], Abnormal GB emptying can be diagnosed in 
patients with a GB EF less than 35%, which may be caused by GB hypokinesia, GB 
dyskinesia, chronic cholecystitis and partial cystic duct obstruction due to gallstone disease 
(Figure 4). 
Figure 4. Representative QHBS recording in a diabetic patient with GB 
hypokinesia and impaired GB contraction (GB EF: 14%) after caerulein (CCKi0) 
administration (1 ng/bwkg/min for 10 min) during the GB phase imaging. TACs were 
selected as follows: LP (white), HH (red), CBD (yellow), GB (blue) and background 
(pink). 
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Augmentation during QHBS, such as CCK or MS administration, has long been 
suggested as a provocation test to enhance the diagnostic aid of scintigraphy [66]. CCK 
augmentation during QHBS may have two different rationales. One is to evoke a paradoxical 
spasm of the SO in a subgroup of patients with SOD and to detect the consequent bile outflow 
obstruction. The other is to facilitate bile flow into the duodenum in patients with GB and late 
duodenal appearance of the radioactivity. CCK increases the hepatic bile secretion and relaxes 
the SO; it therefore washes out the bUe stasis when there is no organic obstruction. This 
design is very similar to that of the Lasix test in isotope renography to rule out renal 
obstruction. MS augmentation has been suggested to induce GB filling due to the enhanced 
SO pressure in patients with suspected chronic cholecystitis and lack of GB activity at 60 min 
[66]. However, the applicability of this stress test is limited, due to some potential serious 
complications, particularly in patients with acute cholecystitis, such as the aggravation of 
biliary colic, the progression of biliary obstruction and the occurrence of GB perforation. 
Although CCK augmentation during QHBS is a rational prospect in the diagnosis of 
functional biliary pain and SOD too, the precise indications and the diagnostic consequences 
of this possible provocative test have not yet been determined. 
2.2. ENDOSCOPIC SPHINCTER OF ODDI MANOMETRY 
The only diagnostic method that allows direct assessment of the motor function of the 
SO is manometry. Accurate pressure measurements from the SO through the endoscope has 
become possible following the miniaturization of manometry catheters and the development 
of low-compliance, fluid-perfusion, pressure-recording systems [22, 23]. Pressure recording 
can be accomplished with a triple-lumen, water-perfused Teflon catheter that is attached to 
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external transducers, and connected to the computer with a multi-channel Polygraf interface. 
For adequate water perfusion and overpressure, a dual-chamber, high-pressure perfusion 
pump may be applied (Figure 5). 
Figure 5. Schematic presentation of the water-perfusion manometric system. 
After selective deep cannulation of the CBD with a standard ERCP catheter, a guide wire is 
placed high up into the CBD. The duct is then entered with the manometric catheter over the 
wire. The direction can be identified by gently aspirating on the proximal channel. The 
appearance of yellow fluid in the endoscopic view indicates entry into the bile duct. Clear 
aspirate indicates the pancreatic duct. In an uncertain case, a small amount of dilute contrast 
media can also be injected. Two different manometric techniques can be applied to determine 
the SO pressure profile: a stationary pull-through and a rapid pull-through technique. During 
the stationary pull-through measurement of SO pressures, the manometric catheter is 
withdrawn from the CBD into the SO zone at 1 mm intervals, and is then stationed in this 
position for a minimum of 4-5 min The SO zone can be identified during ESOM as a zone of 
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a stepwise pressure elevation (baseline pressure) relative to the duodenal and the CBD 
pressure with superimposed PCs [67]. SO BP abnormalities should ideally be observed for at 
least 30 sec and should be reproducibly observed in each lead. PC characteristics such as 
amplitude, frequency and propagation can also be determined with this stationary pull-
through technique (Figure 6). 
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Figure 6. Representative recording of an original stationary pull-through ESOM, made 
in a control patient with normal SO motility and normal SO basal pressure. 
In contrast, the rapid pull-through technique means that the manometric catheter is rapidly 
withdrawn from the CBD into the duodenum at a speed of 1 mm/sec. This manoeuvre should 
be repeated at least 5 times during a single study in order to calculate the average SO BP. 
With the latter technique, the PC characteristics cannot be determined, and artificially high 
pressure values may occur due to movement artefacts and reflex contractions of the SO at the 
time of catheter movement. However, this is the method to measure the length of the SO [68]. 
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ESOM is a troublesome procedure both for the endoscopist and for the patient, since 
premedication should be minimized. Moreover, the difficulty of performing an acceptable 
manometric study necessitates close cooperation between an experienced endoscopist and a 
motility expert. Although the intra- and interobserver reproducibility of ESOM have been 
demonstrated to be reasonably good [69, 70], in a particular patient the correct analysis and 
interpretation of the SO pressure profile can be rather difficult; this is particularly true in 
patients with borderline abnormalities. Some of these problems with the analysis are related to 
the sphincter characteristics, such as the relatively short and narrow SO segment with a 
significant longitudinal and transversal pressure profile asymmetry, while others are related to 
the manometric technique itself, such as spontaneous in-and-out catheter movement during 
the stationary pull-through technique, and reflex sphincter contractions during the rapid pull-
through technique. Artefacts occur quite frequently during ESOM, but their importance is 
considerably underestimated by the literature. Due to these shortcomings, interpretation of the 
tracings is often subjective (Figure 7). The development of new methods, in order to 
recognize and exclude periods of manometric artefacts, is therefore highly necessary. 
Figure 7. The upper panel depicts a 
PC amplitude 
stylized idealistic manometric tracing, 
while the lower panel demonstrates a 
time stylized actual tracing from a patient 
time 
with artefacts, which illustrates the 
potential difficulties in interpretation. 
We prefer to use the stationary pull-through technique for SO BP determination, since 
it has the advantage of allowing a precise longitudinal pressure mapping of the SO with a 
longer measurement period (approximately 8-10 min). The application of this method allowed 
us to detect short periods of SO spasm and/or dyscoordination, together with the detailed 
analysis of the PCs [71]. However, this method is applied, it is extremely important to 
monitor the catheter position and to keep the manometric catheter in exactly the same place 
for a certain period of time, which is sometimes practically impossible, or necessitates 
continuous small corrections by the endoscopist. In our experiments, we performed ESOM by 
applying the stationary pull-through method validated by Funch-Jensen et al. [72]. Following 
an overnight fasting, sedation was induced with 2.5-7.5 mg i.v. midazolam (Dormicum, 
Roche). No other drugs were given. Duodenoscopy was then performed with a video-
duodenoscope JF-130 (Olympus). For SO pressure measurements, a standard triple-lumen 
manometric catheter was used (Arndorfer Med. Spec., USA, and Synectic, Sweden), with an 
external diameter of 1.7 mm and side-holes spaced 2 mm apart. All capillary channels were 
constantly perfused with sterile water at a rate of 0.33 ml/min from a dual-chamber pressure 
pump (MUI Scientific Pump Perfusion System, Mississauqa, Ontario, Canada) with a 14-PSI 
overpressure in the water reservoir. The pressures transmitted by the external transducers 
were recorded simultaneously on a Synectics Medical computer system with a time-correlated 
basis, using Synectics Medical Polygram Windows 1.1 software. Selective deep cannulation 
of the CBD was achieved with a standard ERCP catheter, and a flexible-tip guide wire 
(Wilson Cook HSF 25/400) was then introduced high up into the bile tract. Next, the ERCP 
catheter was changed for the ESOM catheter over the guide wire, which was kept in place. 
The duodenal pressure was recorded before and immediately after the SO measurements in 
order to establish the average zero reference pressure. After the ESOM catheter had been 
placed into the CBD, the guide wire was removed and the CBD pressure was recorded for a 
minimum of 2 min to exclude periods of initial hyperactivity of the SO. A stationary pull-
through measurement of the SO segment was next made. During the stationary pull-through 
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recording, the ESOM catheter was withdrawn into the SO zone and retained there for a 
minimum of 5 min. The SO BP, PC amplitude, frequency and peristalsis were then calculated. 
The amplitude, frequency, duration, and propagation of the PCs were measured in each 
channel, and mean pressure values were calculated. To calculate the maximum SO BP during 
the stationary pull-through technique, we used the manometric channel with the highest 
sustained SO BP occurring for a minimum of 30 sec., after which this high BP pressure can be 
located reproducibly in each of the other channels by the catheter pull-through (Figure 8 ). 
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Figure 8. Representative recording of an original ESOM procedure in a patient 
with SO stenosis and constantly an elevated SO basal pressure. 
During this station pull-through measurement, we determined the average SO BP in all 
channels between the PCs, relative to the duodenal pressure, after careful exclusion of all 
periods with obvious manometric artefacts and periods of duodenal hyperactivity. The mean 
amplitude of the PCs in each channel relative to the SO BP was also determined. The 
frequency of PCs was calculated for the total recording time. The propagation of PCs was 
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analysed for each single PC wave, and the percentages of anterograde, simultaneous and 
retrograde peristalsis were calculated relative to the total activity. With the reference SO 
pressure values obtained by Funch-Jensen in healthy controls, SO BP values exceeding 35 
mm Hg (Figure 9). mean SO PC amplitudes over 200 mm Hg, PC frequencies over 10/min 
(Figure 10), and retrograde PC peristalsis over 50% were considered abnormal (Figure 11) 
[73]. 
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Figure 9. Representative period of elevated SO BP that exceeds 60 mm Hg in the mid 
channel in a patient with SO dyskinesia and periods of SO spasm during ESOM. 
jgy gyp- qjyi» a s M^i 
Figure 10. Giant SO contractions with PC amplitudes that exceed 300 mm Hg 
demonstrated on the left, and tachyoddia (12 PCs/min) on the right. 
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Figure 11. Selected short periods of original ESOM tracings with normal SO BP. 
The left side demonstrates normal propagation of the PCs, while the right side depicts 
typical retrograde peristaltic activity. 
2.3. STATISTICS AND ETHICAL CONSIDERATIONS 
For statistical evaluation, the Student t-tests (paired and unpaired) were used. 
Correlations were analysed by the Spearman rank correlation test, and the correlation 
coefficient was calculated. Significance was achieved at p<0.05. All results are given as 
means with standard deviation and error of the mean, except for the control values, which are 
given as means plus two times the standard deviation (mean + 2SD). Each of the following 
studies was approved by the local ethics committee and was conducted in accordance with the 




3.1. DETERMINATION OF NORMAL PARAMETERS AND DYNAMICS OF BILE 
EMPTYING BY QUANTITATIVE HEPATOBILIARY SCINTIGRAPHY BEFORE 
AND AFTER CHOLECYSTECTOMY 
QHBS has been validated in the diagnosis of cystic duct occlusion due to acute 
cholecystitis and of extrahepatic biliary obstruction caused by stone or stricture. However, the 
diagnosis of minor bile flow abnormalities, frequently occurring in patients with SOD, 
requires a full knowledge of the normal scintigraphic pattern of bile emptying in patients with 
and without the GB. We therefore conducted a prospective study to determine the dynamics 
and normal variations of transpapillary bile flow by QHBS before and after cholecystectomy 
and to calculate reference values for parameters of QHBS in asymptomatic 
cholecystectomized patients [I]. Twenty patients with uncomplicated GB stones were 
investigated (19 women, 1 man, with a median age of 51 years, range 29-70) 1 month before 
and 3 months after laparoscopic cholecystectomy. QHBS was performed with the standard 
method described above. At the time of the study, all of the patients were completely free of 
symptoms. None of them had CBD stones or extrahepatic biliary obstruction. On the basis of 
the results of QHBS, the transpapillary bile flow was judged to be normal in every patient. An 
assessment of the quantitative parameters before and after the operation in the same patient 
group revealed that there were significant differences in the dynamics of CBD emptying 
following cholecystectomy. After cholecystectomy, the isotope emptying from the bile ducts 
was accelerated as compared to the preoperative status (Figure 12). 
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. Time (min) 
No gallstone Cholecystolithiasis After 
disease before operation cholecystectomy N=20 
Figure 12. Comparison of transpupillary bile flow parameters (half-time of excretion) in 
patients without gallstone disease and with the intact GB, and in patients with 
uncomplicated cholecystolithiasis before and after laparoscopic cholecystectomy. 
The parameters of QHBS in cholecystectomized patients and in patients with the intact GB 
are therefore not comparable. In fact, in patients with the intact GB, the bile emptying rates 
vary widely and the CBD emptying can be moderately slow without obstruction. This 
phenomenon is not related to the presence of gallstone disease, since a similar variation in the 
quantitative parameters can be found in patients without gallstones and with an intact GB 
(Figure 12) [XIV]. This wide variation may be explained by the presumption that, during the 
GB filling period with a higher SO resistance, the CBD emptying towards the GB is expected 
to be considerably slower process than during the periods of spontaneous CBD and GB 
emptying through an opened SO into the duodenum. After cholecystectomy, however, the bile 
emptying from the CBD into the duodenum occurs continuously at a higher and constant rate. 
We concluded that in asymptomatic, cholecystectomized patients, only minor variations in the 
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dynamics of bile emptying can be detected by QHBS, thereby increasing the probability of 
identification of abnormalities in patients with SOD. 
The determination of control values is the first step in the assessment of the diagnostic 
value of QHBS in patients with SOD. After quantitative analysis, the Tmax and T| /2 values of 
the LP, HH and CBD, the DAT, the HDTT and the AR were calculated, and the upper limits 
of the normal values (mean + 2SD) were determined in asymptomatic patients after 
cholecystectomy (Table 1). 




LP Tmax 9.7 min 1.8 min 13.3 min 
LP Tm 19.3 min 2.3 min 23.9 min 
HH Tmax 14.3 min 2.6 min 19.5 min 
HHT 1 / 2 19.3 min 2.4 min 24.1 min 
CBD Tmax 21.1 min 4.6 min 30.3 min 
CBD Tj/2 18.8 min 2.6 min 24.0 min 
DAT 16.6 min 3.0 min 22.6 min 
HDTT 2.3 min 1.3 min 4.9 min 
AR 0.98 0.12 1.22 
Table 1. Calculation of the upper limit of the normal range of QHBS in asymptomatic 
patients after cholecystectomy. 
3.2 NEW METHODS FOR THE DIAGNOSIS OF FUNCTIONAL DISORDERS OF 
THE GALLBLADDER AND THE SPHINCTER OF ODDI: 
3.2.1. DIAGNOSIS OF GALLBLADDER DYSKINESIA BY QUANTITATIVE 
HEPATOBILIARY SCINTIGRAPHY 
Recurrent RUQ abdominal pain induced by a fatty meal in patients without 
demonstrable gallstones frequently appears to be, a diagnostic and therapeutic challenge. A 
subgroup of ABP patients exhibits an impaired GB emptying and the reproduction of biliary 
pain after CCK administration. Although GB dyskinesia, i.e. an uncoordinated GB contraction 
with a spasm of the GB neck or cystic duct due to CCK administration, may be responsible 
for this clinical condition, no diagnostic test is yet available to prove this pathogenic 
mechanism. 
Accordingly, we initiated a study to develop a new scintigraphic method in patients 
with ABP and suspected GB dyskinesia [H, XV]. Thirty-eight patients with ABP were 
investigated with our standard QHBS method. In 5 patients without sufficient GB filling at 60 
min, only GTN was administered. In 33 patients with sufficient GB filling, at 60 min after the 
administration of EHIDA, CCKio (Takus, Farmltalia) was infused i.v. in a dose of 1 
ng/kg/min for 10 min The GB EF was then calculated for the period from 60 to 90 min. The 
CCKio infusion was next repeated from 90 min in the presence of sublingually administered 
GTN (0.5 mg) (21 patients) or placebo (12 patients), and the GB EF was once more calculated 
from 90 to 120 min. After the first dose of CCKio, the GB EF was less than 35% in 23 of the 
33 ABP patients, indicating a reduced GB emptying (non-responder (NR) group), while the 
remaining 10 patients had a normal GB EF (responder (R) group). In 16 NR patients, GTN 
and CCKio coadministration induced a significant improvement of the previously impaired 
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GB EF as compared to CCKio alone. In 5 of the 10 patients who exhibited a normal GB EF 
during the initial assessment (group R), GTN and CCKio coadministration caused a further 
increase in GB EF (Figures 13 and 14). 
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Figure 13. Representative hepatobiliary scintigraphy (TACs on the left and analogue 
pictures on the right) on an ABP patient with an obvious improvement of the GB 
contraction due to GTN and CCKjo coadministration as compared to CCK|« alone. 
EF % 
ABP impaired EF ABP normal EF Diabetes 
* p< 0.05 
• GB EF1% 
• GB EF2% 
Figure 14. Effect of GTN on CCK10-evoked GB contraction (GB EF2%) as compared to 
CCKio alone (GB EF1%) in ABP patients with an impaired versus a normal GB EF and 
in patients with diabetic neuropathy. 
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In contrast, in the remaining 7 NR and 5 R patients, placebo and CCKi0 
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Figure 15. Effect of placebo on CCK )0-evoked GB contraction (GB EF 2%) as compared 
to CCKio alone (GB EF 1%) in ABP patients with an impaired vs. a normal GB EF. 
In 16 NR patients where the GB EF was improved following GTN and CCKio 
coadministration, static hepatobiliary scans frequently revealed a scintigraphic sign which we 
have termed GB remodelling. This means that during the first CCKio infusion the GB 
configuration appeared to be spherical in shape and there was no obvious visual evidence of 
GB emptying, with a lack of any activity in the CBD and the duodenum. However, during 
GTN and CCKio coadministration, the GB configuration became oval or pear-shaped, with a 
simultaneous reduction in the amount of the isotope in the GB area, and appearance of the 
isotope in the CBD and the duodenum. Uncoordinated (ineffective emptying) vs coordinated 
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(effective emptying) GB motor responses due to CCKio were always associated with typical 












Figure 16. Note the GB remodelling at the time of effective GB contraction during 
CCKio and GTN coadministration in the lower panel. 
Finally, in patients with incomplete or no GB filling at 60 min, GTN administration 
induced a rapid enhancement of the activity over the GB area, indicating a significant GB 
filling, which was probably due to a cystic duct and/or GB relaxation (Figure 17). 
Figure 17. Representative hepatobiliary scintigraphy on a patient with insufficient GB 
filling at 60 min, which was rapidly enhanced after GTN administration. 
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QHBS was performed with a similar protocol in 8 patients with insulin-dependent 
diabetes mellitus and diabetic neuropathy, demonstrated by cardiovascular reflex tests [XVI, 
XVII]. In this small group of patients GTN coadministration did not improve the CCKio-
induced GB EF. Lack of any effect of GTN on the GB contraction in these patients was 
probably explained by a definite GB hypokinesia due to the diabetic neuropathy (Figure 14). 
Our results provided the first evidence that GTN causes a significant improvement in 
the CCKio-induced GB emptying in patients with ABP. Normalization of the GB EF in the 
majority of ABP patients following GTN and COKio coadministration suggests a functional 
disorder rather than an organic biliary abnormality. We have also demonstrated a new 
scintigraphic sign of GB remodelling, which may be regarded as visual evidence of the 
functional spasm of the cystic duct at the time of ineffective GB emptying. In patients with no 
or late GB filling, we proved that GTN administration induced a rapid and complete GB 
filling. In patients with diabetic neuropathy, the GB EF was unaffected by GTN 
augmentation, indicating that the application of this method permitted the separation of those 
patients with definite GB hypokinesia. From these results, the following conclusions could be 
drawn. First, GTN administration alone facilitates GB filling, which may be explained by a 
primary relaxing effect of GTN on the cystic duct and/or the GB. Secondly, GTN and CCKio 
coadministration induces a significant improvement of the GB EF in patients with ABP and 
GB dyskinesia, which is probably induced by a NO-mediated cystic duct relaxation at the 
time of CCKio-evoked GB contraction. Finally, QHBS combined with simultaneous GTN and 
CCKio administration may be regarded as a prospective new method in the diagnosis of 
functional spasm of the cystic duct in patients with ABP. Furthermore, the differentiation of 
patients with GB dyskinesia from those with primary abnormalities of GB contraction, such 
as GB hypokinesia due to diabetic neuropathy, can also achieved with GTN and CCKio 
augmentation during QHBS. 
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3.2.2. DIAGNOSIS OF BILE FLOW ABNORMALITIES IN PATIENTS WITH 
SPHINCTER OF ODDI DYSKINESIA BY QUANTITATIVE 
HEPATOBILIARY SCINTIGRAPHY 
QHBS is a useful method to assess disturbances of bile flow, and it was therefore 
suggested as a simple screening test in patients having postcholecystectomy biliary pain and 
suspected SOD. However, the clinical acceptance of QHBS has progressed only gradually, 
since it has been demonstrated that overlaps may exist between normal populations and 
patients with SOD. Furthermore, there is still uncertainty as to which is the most sensitive 
scintigraphic parameter for the selection of patients with SOD, and how to measure this 
parameter. 
Accordingly, to investigate the diagnostic value of QHBS in patients with suspected 
SOD, we performed a prospective scintigraphic investigation in a group of 
cholecystectomized patients with suspected SOD and biliary pain similar to that before the 
operation [HI]. In this study, we compared the results with those obtained in our 
cholecystectomized control group mentioned above [m]. During this study, we investigated 
20 cholecystectomized patients (17 women and 3 men, with a median age of 50 years, range 
27 - 68 years) with suspected SOD by means of QHBS. All 20 patients were referred to the 
Hvidovre Hospital for postcholecystectomy pain syndrome, indicated by RUQ or epigastrial 
pain being similar to that before the operation, but without any organic explanation. Twelve 
of the 20 patients (57 %) had concomitant dyspeptic symptoms (i.e. nausea, vomiting, early 
satiety and bloating) too. The questionnaires revealed that the median time of the onset of 
symptoms after cholecystectomy was approximately 1.5 years. Apart from the diagnostic tests 
necessary to exclude extrabiliary organic diseases (laboratory tests, upper GI endoscopy and 
abdominal ultrasonography), diagnostic ERCP was performed in all patients before their 
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inclusion in the present study. The ERCP and liver function tests were normal in the majority 
of the patients, 2 displayed a moderate CBD dilation without an obvious cause, and 3 had a 
moderately elevated AST on admission. On Geenen's classification, these patients belonged 
in the SOD groups of biliary types II and III. 
QHBS was performed with the standard method described above, and the quantitative 
parameters were then and compared with those for the control group described above. In 7 of 
the 20 patients, the static hepatobiliary scintigram revealed a significant accumulation of the 
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Figure 18. The upper panel depicts a static hepatobiliary scintigram of a control patient 
with normal bile flow, and the lower panel that of a patient with SOD and accumulation 
of the isotope in the biliary tree. 
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The transpupillary bile flow differences between the two groups were more obvious 
after the quantitative analysis. The TACs over the HH and CBD tended to show an 
accumulation pattern in most of the patients with suspected SOD (Figure 19). 
Figure 19. Representative QHBS result in a patient with SO dyskinesia, demonstrating 
the typical accumulation pattern of the TAC over the CBD. 
In patients with suspected SOD, calculated from the ROI over the CBD, and also 
the DAT, HDTT and AR values were significantly higher than those in the controls. These 
results called attention to the parameters HDTT and AR, which proved to be highly sensitive 
with only a moderate overlap between the controls and the SOD patients, despite the inclusion 
of patients with SOD of biliary types II and III, i.e. mainly the patients with SO dyskinesia. 
When the individual values of the patients were compared with the upper limit of the normal 
values, 14 of the 20 patients with suspected SOD had at least one abnormal quantitative 
parameter. These results indicated that HDTT and AR should be applied for the detection of 
bile flow abnormalities in patients with SO dyskinesia (Figure 20). 
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Figure 20. Comparison of the QHBS results on the controis and on the patients with 
SOD of biliary types II and III. 
This study allowed the conclusion that QHBS is a sensitive method for the detection 
of bile flow abnormalities in patients with SO dyskinesia. In this respect, AR and HDTT 
proved to be the most sensitive parameters, with only moderate overlap between the SO 
dyskinesia patients and the controls. Accordingly, we can suggest the application of QHBS as 
a simple screening test in the diagnostic strategy of patients with postcholecystectomy 
symptoms and suspected SO dyskinesia before the application of risky and invasive 
investigations such as ESOM. 
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3.2.3. DIAGNOSIS OF SPHINCTER OF ODDI MOTILITY DISORDERS IN 
PATIENTS WITH SPHINCTER OF ODDI DYSKINESIA BY 
VIDEOMANOMETRY 
Videomanometry of the SO is a fundamentally new technique of manometric analysis, 
which was originally proposed for the comparison of fluoroscopic pictures of ERCP and 
pressure recordings of the SO. This technique became possible only after the introduction of 
the new Windows version of the Polygram analysis software developed by Synectics Co, 
whereby we are able to record video movies and pressure recordings simultaneously on an 
exact time-correlated basis. We initially developed this new method to compare 3-channel 
ESOM pressure recording and real-time fluoroscopic pictures of ERCP. The recording speed 
of the fluoroscopic movie was 15 pictures/sec. Separate and independent qualitative analyses 
of the SO peristaltic activity on fluoroscopy, and the SO phasic activity on manometry, 
allowed some important physiological observations [XVIII], Bile emptying from the CBD 
into the duodenum always occurred at the time of concomitant PCs on ESOM. Furthermore, 
periods of intra- and inter-PC activity on ESOM corresponded exactly to the systolic and 
diastolic phases of the SO on fluoroscopy (Figure 21). 
Figure 21. Relationship between peristaltic activity of the SO on fluoroscopy and PC on 
ESOM. The left side demonstrates a SO systole on fluoroscopy and the lack of PC on 
ESOM, while on the right side is a SO diastole at the time of a propagating PC on 
ESOM with a transient pressure drop at this moment of bile emptying. 
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Analysis of ESOM can be difficult because of the occurrence of manometric artefacts, 
as discussed previously, which might influence the reproducibility too. However, there was 
earlier no objective method to recognize and exclude these periods from the manometric 
tracings. It is obvious that personal attendance and participation at the manometric 
investigation makes the tracing analysis easier afterwards. This led to the proposal that 
availability of the real-time recorded duodenoscopic movie during the manometric tracing 
analysis could be extremely useful to exclude artefacts. Accordingly, we conducted a 
prospective study to develop a new method, videomanometry of the SO, based on 
simultaneous manometric pressure and real-time endoscopic picture analysis during the 
ESOM procedure [IV]. The aims of this study were to describe and document the most 
frequent manometric artefacts, to investigate the usefulness of videomanometry for the 
detection of manometric artefacts during ESOM; and to analyse the effects of duodenal 
contractions on the SO manometric pressure profile by means of videomanometry. In 7 
consecutive patients, both computer and analogue recording of the video endoscopic movie 
was performed at a frame rate of 15 pictures/sec during the ESOM investigation. The ESOM 
and real-time endoscopic picture analysis results were evaluated separately and compared on 
a time-correlated basis. The most frequently recognized artefacts that occurred during the 
ESOM procedures were retching, catheter movement-induced pseudo-contractions, duodenal 
contractions and ventilation artefacts (Figure 22). 
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Figure 22. Videomanometric documentation of the most frequent manometric artefacts. 
Demonstrative pictures of artefacts such as retching (upper left), major catheter 
movement-induced pseudo-contractions (upper right), duodenal contractions (lower left) 
and hyperventilation-induced pseudo-contractions (lower right). 
Retching caused a sudden, simultaneous, high and narrow pressure rise in all 3 
channels, with an amplitude up to 200 mm Hg and a duration of less than 2 sec. Major 
movements of the manometric catheter into and out of the SO gave rise to the phenomenon of 
pseudo-contractions. These in-and-out movements of the catheter may also be due to the 
transmitted effect of the hyperventillation with an amplitude and duration quite similar to 
those of real SO or duodenal contractions. However, we found that pseudo-contractions were 
always simultaneous in all 3 channels and they usually exhibited a reciprocal or mirror 
phenomenon in channels I and III. Duodenal contractions could readily be differentiated from 
the real SO contractions by having a lower amplitude, a shorter duration and a slower but 
definite propagation. Duodenal contractions can also be easily recognized on 
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videomanometry. In fact, we found that the availability of the RTEPA is extremely useful at 
the time of ESOM analysis. With the aid of videomanometry, we could continuously monitor 
the duodenal activity and the catheter position as well, and therefore we could detect the exact 
positions of the measurement periods and explain most of the unexpected baseline 
undulations. The frequencies of the previously-described artefacts were scored during the 
ESOM tracing analysis and then compared. The most frequent artefacts were due to duodenal 
contractions, followed by pseudo-contractions, and then by retching. When the results of real-
time endoscopic picture analysis were compared with the ESOM tracing, we found that in 
78% of all duodenal contractions a corresponding pressure wave could be detected in the 
ESOM tracing, with an average amplitude of 71.9 + 16.7 mm Hg and a duration of 2.8 ± 0.4 
sec. However, the manometric characteristics (amplitude, duration and frequency) of the PCs 
originating from the SO and from the duodenum were different, since true SO PCs had a 
significantly higher amplitude and longer duration, with an average amplitude of 153.9 ± 85.0 
mm Hg and a duration of 7.9 +.1.2 sec (Figure 23). 
Figure 23. Peristaltic SO PC on ESOM without any visible duodenal activity or other 
artefact on the videomanometry pictures. 
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From these results, it became obvious that duodenal contractions were not only visible 
in the ESOM tracing, but could also induce significant pressure rises in the SO zone and they 
might therefore influence the bile outflow even without simultaneous genuine SO motor 
activity [XIX]. We proved that, apart from duodenal contractions, the catheter movement is 
the most problematic issue, since it can cause instability of the BP and lead to the formation 
of pseudo-contractions. With the help of videomanometry, the position of the manometric 
catheter can be continuously monitored with the ring marks outside the papilla. After the 
exclusion of all periods of manometric artefacts, the diagnosis of SO motility abnormalities 
can be made more effectively. In conclusion, videomanometry of the SO is a promising new 
method, which can be used as an aid for correct tracing analysis, for the exclusion of 
manometric artefacts and to improve tracing documentation. Application of videomanometry 
of the SO in clinical practice is recommended. 
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3.2.4. ASSESSMENT OF FLOW PRESSURE RELATIONSHIP BY COMPARISON 
OF THE RESULTS OF QUANTITATIVE HEPATOBILIARY 
SCINTIGRAPHY AND ENDOSCOPIC SPHINCTER OF ODDI 
MANOMETRY IN PATIENTS WITH SPHINCTER OF ODDI DYSKINESIA 
Since ESOM is regarded as the gold standard for the diagnosis of motility disorders of 
the SO, an assessment of the exact diagnostic value of QHBS is not possible without a 
comparison of the results of these methods in the same group of cholecystectomized patients 
with suspected SOD. Therefore, we conducted a prospective study to investigate the same 
group of patients by means of QHBS and ESOM [III]. Both QHBS and ESOM were 
performed by applying our standard methods, as described previously. Twenty 
cholecystectomized patients with suspected SOD were investigated (17 females and 3 males, 
mean age 50 years) by means of QHBS and then ESOM. All patients had biliary pain similar 
to that before the operation, and they belonged in the SOD groups of biliary types II and III. 
QHBS was performed in all 20 patients, but ESOM could be completed only in 15 patients. 
Dropouts were due to poor patient cooperation in 3 cases, and to technical difficulties, such as 
an inability to introduce the manometric catheter into the CBD in 2 cases. No complications 
occurred after QHBS. However, after manometry, mild pancreatitis occurred in 5 of the 15 
patients (33%), manifested by abdominal discomfort and a transient serum amylase elevation 
on the day of the investigation. All patients could be discharged one day after the ESOM 
procedure without long-term complications. Nine of the 15 symptomatic patients exhibited an 
elevated SO BP (over 40 mm Hg) on ESOM, while in the remaining 6 patients the SO BP was 
normal. A predominantly retrograde PC peristalsis was found in 4 patients, all but one 
accompanied by an elevated SO BP. In this series of 15 patients, no tachyoddia or increased 
PC amplitudes were observed. We diagnosed SO motility abnormalities in 10 of the 15 
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patients (67%) with postcholecystectomy pain and suspected SOD, most of them having an 
elevated SO BP, which always normalized in response to CCKio administration. 
In those 15 patients with successful ESOM and QHBS, we were able to compare the 
pressure values and the bile flow parameters. On the basis of the ESOM results, we divided 
the patients into two groups: 9 patients with an elevated SO BP (over 40 mm Hg) and 6 
patients with a normal SO BP (under 40 mm Hg). The QHBS parameters in the two patient 
groups with a normal or an elevated SO BP were then compared with the results on our 20 
asymptomatic cholecystectomized controls (described in section 3.1.). In the 9 patients with 
an elevated SO BP, the Tmax. and T\a values calculated from the ROIs over the HH and CBD, 
HDTT, DAT and AR were significantly increased as compared to the values obtained in the 
controls or in the patients with a normal BP. In the remaining 6 patients with a normal SO BP, 
the QHBS parameters did not differ significantly as compared with those for the control 
group. Moreover, no overlap of QHBS parameters was observed in the SOD patients with 
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Figure 24. Comparison of the results of QHBS in patients with biliary pain and normal 
versus elevated SO BP and in asymptomatic controls. The upper panel depicts the Tmax 
and Tj/2 parameters of CBD emptying, while the lower panel relates to DAT and HDTT. 
Finally, in order to establish a possible relation between the flow parameters derived 
from QHBS and the pressure values calculated from ESOM, we systematically compared our 
quantitative parameters by the Spearman rank correlation test. For the pooled data on 15 
symptomatic patients with suspected SOD, a statistically significant linear correlation was 
found between the SO BP and all of the QHBS parameters: SO BP vs. LP Tmax (R = 0.69, p = 
0.005); SO BP vs. LP Tm (R = 0.84, p = 0.00009); SO BP vs. HH Tmax (R = 0.82, p = 
0.0002); SO BP vs. HH T1/2 (R = 0.79, p = 0.0005); SO BP vs. CBD Tmax (R = 0.65, p = 
0.008); SO BP vs. CBD T,/2 (R = 0.68, p = 0.005); SO BP vs. HDTT (R = 0.72, p = 0.003); 
and SO BP vs. DAT (R = 0.89, p = 0.00001) (Figure 25). However, no statistical relationship 
was detected between the QHBS parameters and the amplitude, frequency and propagation 
characteristics of the SO PCs. 
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Figure 25. A significant linear correlation was established between the SO BP values 
determined by ESOM and the transpapillary bile flow parameters measured by QHBS. 
Calculation of the upper confidence limits of the normal values (mean + 2 SD) of 
each QHBS parameter in the control group allowed us to determine the sensitivity and 
specificity of QHBS in the diagnosis of SOD with an elevated SO BP. Although HDTT was 
the most sensitive scintigraphic parameter for the detection of an elevated SO BP (89%), 
DAT, T1/2 of the CBD, and AR proved to have excellent sensitivities of 78%, 78% and 67%, 
respectively. In fact, the combined sensitivity of Tmax and T1/2 of the CBD reached 100%. 
Hence by a simple quantification of the CBD TACs, we were able to identify all patients who 
had an elevated SO BP on ESOM. The specificity turned out to be 100% for all QHBS 
parameters, which was obviously due to the highly preselected patient cohorts, and should 
also be evaluated with regard to the limited number of patients. 
These results permitted the following conclusions. A significant correlation has been 
established between the bile flow parameters measured by QHBS and the SO BP determined 
by ESOM. The SO BP has a critical influence on the transpupillary bile flow in 
cholecystectomized patients. QHBS proved to be a sensitive and specific method in the 
differentiation between patients with a normal or an elevated SO BP. Therefore, QHBS is a 
useful non-invasive method for the diagnosis of SOD patients with an elevated SO BP. 
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3.2.5. DIAGNOSTIC VALUE OF AMYL NITRITE AND CAERULEIN 
AUGMENTATION DURING QUANTITATIVE HEPATOBILIARY 
SCINTIGRAPHY AND ENDOSCOPIC SPHINCTER OF ODDI 
MANOMETRY IN PATIENTS WITH SUSPECTED SPHINCTER OF ODDI 
DYSKINESIA 
SO dyskinesia is a primary functional abnormality of the SO, where the SO responds 
with exaggerated spasm to various physiological stimuli. During these periods of dysmotility, 
transient elevation of the SO BP (also described as dyscoordination) and abnormal 
transpapillary bile flow can be detected by means of ESOM and QHBS. The diagnostic 
characteristic of SO dyskinesia is that these transient elevations of the SO BP can be relieved 
after by CCKio or AN administration. Normalization of the elevated SO BP following the 
administration of CCKio or AN during ESOM suggests dyskinesia rather than organic 
stenosis of the SO (Figure 26). 
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Figure 26. The upper panel demonstrates the effect of AN, and the lower panel that of 
CCKio on the SO pressure profile in patients with SO dyskinesia. Note the obvious drop 
in SO BP after the administration of either SO relaxants. AN had only a minor influence 
on the PCs, whereas CCKio completely abolished them. 
Non-invasive differentiation between SO dyskinesia and SO stenosis would be 
extremely valuable during QHBS with augmentation of the bile flow with SO relaxants. 
Therefore, we developed a new scintigraphic method, referred to as AN-augmented QHBS, to 
differentiate patients with organic and functional obstruction at the level of the SO [V]. The 
rationale of this study was based upon the assumption that AN administration would cause 
relaxation in all functional obstructions of the SO, and the bile flow changes due to the action 
of AN could be detected by QHBS. QHBS was performed with our standard method as 
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described above, except that from the 60th min. until the end of the examination, AN (dosage: 
1 ml of 45 mg/ml solution per patient) inhalation was applied. During the quantitative analysis 
of the scintigraphy, apart from the regular parameters, the 1j/2 of the CBD was calculated for 
both pre- and post-AN periods (T\a and T|/2a). CBD EF (%) was then calculated as a 
percentage of the CBD activity change after AN administration as compared to the CBD 
activity before the pharmacological stimulus. With these quantifications, the effect of AN 
administration on the transpapillary bile flow could be expressed numerically, and patients 
with SO stenosis and SO dyskinesia could be readily differentiated [V] (Figure 27). 
Figure 27. Pictures summarizing the results of AN-augmented QHBS investigation in a 
patient with SO dyskinesia (CBD T1/2: 63 min, CBD T,/2a: 12 min, CBD EF%: 87%) on 
the left, and in a patient with SO stenosis (CBD T w : > 90 min, CBD T,/2a: 79 min, CBD 
EF%: 23%) on the right. The upper panel presents parametric and cumulative pictures, 
and the lower panel TACs (LP: white, HH: red, CBF: yellow). CBD EF was calculated 
by applying the formula CBD EF (%) = (I0-Ii)/Io x 100. 
We recently conducted a retrospective study aimed at evaluating the usefulness of AN 
augmentation in patients with suspected SOD for the differentiation of patients with structural 
stenosis (SOD of biliary type I) and functional dyskinesia (SOD of biliary type II or III) [XX]. 
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AN-augmented QHBS was performed on 66 patients with suspected SOD (mean age: 60 
years; 61 female and 5 male). Of these 66 patients, 9 belonged in the SOD group of biliary 
type I, 38 in the SOD group of biliary type II, and 19 in the SOD group of biliary type III. All 
patients had been cholecystectomized (an average of 10 years before the investigation) and 
had RUQ abdominal pain similar to that before the operation. QHBS revealed a marked 
obstructive pattern in all 9 SOD patients of biliary type I, and AN administration did not 
induce significant changes in the parameters of CBD EF% and Ti/2a for the CBD. In the 38 
patients with SOD of biliary type II and the 19 patients with SOD of biliary type III, QHBS 
revealed a partial obstructive pattern of the transpapillary bile flow, which was significantly 
improved by AN administration, indicating a functional obstruction at the level of the SO. 
However, in those patients in the SOD group of biliary type III (i.e. purely functional group), 
the acceleration of the rate of CBD excretion was so prominent that T\aa for the CBD not only 
decreased significantly, but also normalized during AN administration. Moreover, we found 
significant differences between the results for the SOD I, II and III patients as regards both the 
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Figure 28. The upper diagram compares T m and T ) /2a for the CBD in the SOD patients 
in groups of biliary types I, II and III, while the lower diagram compares the CBD EF% 
values. Tj/2 for the CBD before AN augmentation is not useful for separation of these 
groups, but both Ti/2g and CBD EF are significantly different, with only a moderate 
overlap. 
Another innovative approach could be the use of CCK or its analogue CCKio in an 
attempt to enhance the transpapillary bile flow in patients with partial biliary obstruction on 
QHBS. In order to investigate the effect of CCK on the bile flow in cholecystectomized 
patients, we conducted prospective studies in patients with suspected SO dyskinesia [III, XXI, 
XXII, XXIII]. During QHBS at the 60th min, we administered 5 ng/bwkg/min CCK,0 (Takus) 
i.v. for 10 min. Tj/2 for the CBD was then calculated before and after CCKio administration 
(T ! /2 and Ti/2C). After the administration of CCK|0 during QHBS, the rate of bile excretion 
from the CBD was accelerated and T1/2 for the CBD was decreased significantly (Figure 29). 
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Figure 29. The upper panel depicts a representative CCKio-augmented QHBS in a 
patient with partial biliary obstruction due to SOD that was completely relieved after 
CCKio administration at the 60th min. The lower diagram presents the results of CCK )0-
augmented QHBS in patients with SOD of biliary types II and III. CCKi0 augmentation 
significantly accelerated the transpapillary bile flow in both groups. However, the CBD 
T1/2 did not differ significantly in the two groups of patients, regardless of the effect of 
CCKio administration. 
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This effect of CCKio was uniform, regardless of the SOD staging, or the previous 
scintigraphic or manometric result. No scintigraphic or manometric signs of a paradoxical 
response to CCK (i.e. accumulation of the isotope due to SO spasm) were detected. It must be 
emphasized therefore, that in contrast with AN, CCKio administration diminished the previous 
differences in the transpupillary bile flow. 
These studies permitted the following conclusions. AN-augmented QHBS allows a 
non-invasive differentiation between organic stenosis and functional motor abnormalities of 
the SO. The results of AN-augmented QHBS closely correlated with the SOD staging, based 
on morphologic criteria. The clinical staging of SOD could therefore be assessed by the 
application of AN augmentation during QHBS. In contrast, CCK augmentation uniformly 
accelerated the transpupillary bile flow in every patient, therefore masking the previous 
differences. No paradoxical response of the SO was detected after CCK augmentation, 
making this test inadequate as an evocative method. 
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3.2.6. d i a g n o s t i c v a l u e o f p r o s t i g m i n e a n d m o r p h i n e 
a u g m e n t a t i o n d u r i n g q u a n t i t a t i v e h e p a t o b i l i a r y 
s c i n t i g r a p h y i n p a t i e n t s w i t h s u s p e c t e d s p h i n c t e r o f o d d i 
d y s k i n e s i a 
It is assumed that in patients with SO dyskinesia, the SO responds with a functional spasm 
(periods of elevated SO BP) to various exogenous stimuli, such as emotional, physical or 
pharmacological stress [30]. As concerns the subjective complaints of these patients, these 
symptomatic periods are completely unpredictable; they recur randomly and sometimes only 
occasionally after a certain period. Most of the attacks resolve spontaneously within a few 
hours, i.e. sometimes without medical attention. It is also likely that, even with detailed 
investigations in these SO dyskinesia patients neither morphological nor functional 
disturbances can be detected during the dominant asymptomatic periods of the disease. 
Accordingly, evocative tests have long been utilized as the only possibility suggested to 
demonstrate functional abnormalities in these patients. Provocation tests involving CCK 
augmentation have been proposed, but their diagnostic usefulness is questionable, since the 
paradoxical response of the SO is believed to be a rare phenomenon [74]. Evocative tests 
utilizing MS administration, such as the Debray and Nardi tests, were intended to identify this 
subgroup of patients with SO dyskinesia through the possible hyperreactivity of the SO due to 
MS, but the diagnostic value of these tests has been criticized in consequence of their poor 
reproducibility and low specificity. This was mainly due to the fact, that their diagnostic 
scoring system was based only on an assessment of subjective complaints, which can be 
completely unreliable in a patient with functional abdominal pain [41]. Moreover, MS may 
induce segmental spasm of the small bowel without SO spasm, which can be painful in 
patients with irritable bowel syndrome. Therefore, Varro et al. suggested that the diagnostic 
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accuracy of these provocation tests might improve through a combination of liver enzyme 
determination and hepatobiliary scintigraphy, in order to prove that the SO spasm really 
existed at the time of the subjective complaints [75]. However, without the quantification of 
hepatobiliary scintigraphy, this method was not sensitive enough to make a real distinction 
between controls with physiological responses and patients with exaggerated responses and 
SO spasms after MS administration. In order to improve the diagnostic value of the original 
method with the advent of QHBS, we conducted a prospective study in 22 patients with 
suspected SO dyskinesia [VI]. All patients belonged in the group with SOD of biliary type III. 
After a basic scintigraphic study a few days earlier, QHBS was combined with a prostigmine-
morphine test in all patients as follows. After an overnight fast, 10 mg MS was administered 
s.c. Thirty min. later, 0.5 mg prostigmine was injected i.m., and 140 MBq EHIDA was 
administered i.v. Subjective complaints were recorded, and the serum levels of AST and 
amylase were determined at the beginning and 2, 4 and 6 hours following MS administration. 
In 12 of the 22 patients (55%) (Nardi-positive group), QHBS revealed a biliary obstruction 
after MS administration, and Tmax over the CBD and the DAT were significantly increased as 
compared to the corresponding data obtained without provocation (Figures 30 and 32). 
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Figure 30. Complete functional obstruction at the level of the SO, due to MS 
administration, in a patient with a positive Nardi test on the right, and normal bile flow 
during the baseline QHBS study without provocation on the left, in the same patient. 
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In the remaining 10 patients (45%) (Nardi-negative group), no obstructive pattern was 
detected in the hepatobiliary scintigram, and QHBS revealed the free transpapillary flow of 
the tracer. In this Nardi-negative group, Tmax over the CBD and the DAT were not changed 
significantly as compared with the baseline QHBS study (Figures 31 and 32). 
Figure 31. MS has only a subtle effect on bile flow in a Nardi-negative patient on the 
right as compared with the baseline QHBS study on the left. 
CBD Tmax DAT 
Figure 32. The QHBS parameters are markedly increased in Nardi-positive patients as 
compared with those in the Nardi-negative group or in the basic study. 
The combination of QHBS and Nardi test has led to the non-invasive visualization of 
the MS-induced exaggerated SO spasm in SO dyskinesia patients, which is probably due to a 
hyperreactive response of the SO to MS administration. Moreover, there was an excellent 
correlation between the MS-induced AST rises and the QHBS parameters. All 12 patients, 
who were judged to be Nardi positive on the basis of the results of QHBS had a significant 
AST elevation. In feet, in 4 of these 12 Nardi-positive patients, the AST elevation was less 
than twofold, so it did not reach the diagnostic level. However, none of the 10 patients who 
gave negative QHBS results exhibited significant AST changes. 
In contrast, no correlation was observed between the QHBS results and the subjective 
complaints of these patients during the Nardi test. 16 patients complained of upper abdominal 
pain during prostigmine-morphine provocation, whereas only 12 had a SO spasm according to 
the QHBS results, providing evidence that abdominal pain alone is not a specific sign, and 
should not be used as a diagnostic criterion. 
These studies furnished the following conclusions. QHBS is an excellent method for 
visualization of the prolonged SO spasm during the prostigmine-morphine provocation test. In 
patients with SO dyskinesia and a positive Nardi test, QHBS revealed a characteristic 
obstructive pattern over the CBD, indicating that a sphincter spasm really does exist at the 
time of the evoked biliary pain. This method allows a clear distinction of patients who give a 
physiological response to morphine administration from those who respond with an 
exaggerated sphincter spasm due to hyperreactivity of the SO. QHBS combined with the 
prostigmine-morphine test should therefore be regarded as a useful method with which to 
improve the diagnostic accuracy of the conventional Nardi test. Clinical application of this 
test might be a real prospect in the diagnosis of SO dyskinesia in the future. 
4. d i s c u s s i o n 
Despite the recent advances in the fields of functional GI disorders and GI motility, 
the diagnosis of biliary dyskinesia is still difficult, as many of the available methods are not 
sufficiently sensitive or specific. ESOM has been growing in acceptance in the diagnosis of 
SO dyskinesia, although it is an imperfect standard, being invasive with a significant 
procedure-related morbidity. Non-invasive examinations have therefore been introduced and 
suggested as a possible alternative to ESOM. QHBS originally showed promise as a widely 
available non-invasive method that is easy to perform. Nevertheless, as a definite diagnostic 
test in patients with SOD, it must meet the following requirements. First of all, significant bile 
flow differences should be documented by QHBS between normal controls, patients with 
hepatocellular diseases, and patients with SOD. Next, it should be noted how cholecystectomy 
itself alters the transpapillary bile flow pattern. Furthermore, it must be established which is 
the most sensitive scintigraphic parameter to differentiate between controls and SOD patients, 
and how to measure it. The sensitivity and specificity of the QHBS parameters should then be 
reasonably good as compared with those of ESOM. Finally, a differentiation between organic 
and functional causes of bile flow abnormalities is necessary in order to determine disease 
severity and optimal therapy. 
In the present work, our main proposals were to deal in detail with these problems, and 
to establish the diagnostic role of QHBS in patients with biliary dyskinesia. First, we 
determined the control values in a group of patients before and after cholecystectomy. These 
results can be utilized to determine whether the transpapillary bile flow is accelerated after 
cholecystectomy and occurs more constantly as compared with the preoperative status, 
therefore increasing the probability of the identification of abnormalities in patients with SOD 
[I]. It is well known that there are variations in the normal pattern of bile emptying [62], but 
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the effect of cholecystectomy on the bile flow had not been investigated previously. Our 
results made it obvious that there are wide variations in bile emptying from the CBD into the 
duodenum preoperatively, even in the absence of a biliary obstruction, a phenomenon which 
may lead to interpretation errors during the analysis of QHBS in patients with suspected SOD 
an GB. In patients with an intact GB and suspected SOD, therefore ESOM must be performed 
to establish the diagnosis [I]. 
The next step was to investigate whether QHBS could be suggested as an initial 
screening test in patients with suspected SOD. To test this theory, we compared the results of 
QHBS in patients with postcholecystectomy pain and suspected SOD and in asymptomatic 
cholecystectomized controls [III]. We demonstrated, that when the patient selection was 
adequate and the optimal quantitative parameters were selected and applied, there were 
significant differences and only moderate overlaps between patients with suspected SOD and 
cholecystectomized controls. Our findings revealed that Tmax and T\a of the CBD, DAT, 
HDTT and AR were the most sensitive parameters for the detection of transpapillary bile flow 
abnormalities in patients with suspected SOD. Although these results had been postulated in 
the literature, no previous investigators had been able to demonstrate such a clear distinction 
As concerns the diagnostic value of QHBS in cholecystectomized patients with 
suspected SOD, a crucial question is whether QHBS .is an accurate method for the selection of 
SOD patients when the results are compared with those of ESOM. For the pooled data on the 
symptomatic patients with suspected SOD, we found a statistically significant linear 
correlation between the SO basal pressure and the QHBS parameters [III]. Our results are in 
accordance with those reported by Corazziari et al. [76]. Previous investigations had revealed 
that QHBS has a high sensitivity (83-100%) and specificity (100%) for the diagnosis of SOD 
as compared with the results of ESOM [77-80]. The main criticism of those studies is that 
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they were performed in a group of patients mainly with SOD of biliary type I, with a 
clinically obvious biliary obstruction involving CBD dilatation [77, 78]. However, a dilated 
CBD may be associated with a slow transpapillary bile transit even without a SO motility 
disorder [75]. In contrast, we were able to demonstrate bile flow disturbances not only in 
patients with SO stenosis (biliary group I), but also in patients with SO dyskinesia (SOD 
biliary groups II and HI). The second questionable point is the uniformly 100% specificity 
with high sensitivity, which at first sight appears incredible [79, 80]. The reason for this 
finding could be that the selection of these patients was based on the exclusion of other 
organic GI disorders. In clinical practice, the diagnosis of functional GI disorders is exclusive, 
and this high specificity is therefore a natural consequence of a correct diagnostic strategy. 
Moreover, QHBS and ESOM should be applied as functional methods and not to investigate 
morphology or to differentiate between organic biliary disorders. Our results proved an 
excellent correlation between the QHBS parameters and the SO BP determined by ESOM, 
which suggests that from this aspect these methods are comparable. After the separation of 
patients with SOD on the basis of an elevated SO BP determined by ESOM, the quantitative 
parameters of HDTT, DAT, AR and CBD emptying were significantly different from those of 
cases with a normal SO BP, and also from those of the controls. In fact, the combined 
sensitivity of Tmax and T m of the CBD reached 100%, i.e. quantification of the CBD TAC 
allowed us to select all patients who had an elevated SO BP on ESOM. The specificity turned 
out to be 100%, which was obviously due to the strong preselection of the patient population, 
and which is certainly not the case if QHBS is applied as an initial screening test. Therefore, 
our results indicate that, afler the exclusion of organic disorders, QHBS is a reliable method 
for the identification of SOD patients with an elevated BP [III]. 
Further improvement of the diagnostic value of QHBS may be achived by the 
differentiation of SO dyskinesia patients from those with an organic biliary obstruction, such 
as strictures, CBD stones or SO stenosis, which might furnish identical findings on QHBS. 
Such a diagnostic application of QHBS may be possible following the administration of SO 
relaxants to document the functional spasm in patients with SO dyskinesia. Accordingly, we 
developed and introduced a new scintigraphic method in which the QHBS procedure was 
combined with, the concomitant administration of AN, which is a potent smooth muscle 
relaxant [V]. This new method can be applied to measure the AN-evoked acceleration of the 
bile flow due to SO relaxation in patients with SOD. With this augmentation, QHBS has 
become a real functional test. We later demonstrated that untreated hyperlipidaemia might 
alter the relaxatory effect of NO on the SO [XXIV, XXV], but this phenomenon does not 
exert a major influence on the diagnostic efficacy [XX]. AN augmentation is a highly 
effective method for the induction of SO relaxation in all patients who have a functional 
obstruction of the SO due to SO dyskinesia. In this way, functional and organic causes of 
biliary obstruction can be differentiated and the accuracy of QHBS has been further increased 
[V]-
The intermittent nature of the complaints of patients with SO dyskinesia is well 
known, though it is rarefy mentioned in clinical practice. This periodicity of the symptoms in 
these patients suggests that SO motility abnormalities can also occur intermittently. The 
intermittent occurrence of SO dysmotility might be due to simultaneous alterations of 
duodenal motility [XXVI, XXVII]. However, an assessment of the SO function with ESOM 
or QHBS is possible only over short periods. One potential solution of this difficulty is the 
use of provocation tests during ESOM or QHBS; these might unmask abnormalities which 
might be missed by the standard methods. The pharmacological provocative tests suggested 
for the diagnosis of functional biliary pain are based on the administration of MS and CCK 
[40, 81, 82]. The reproduction of biliary pain is required for a positive result in these 
provocation tests, in consequence of either the hyperreactivity and/or the hypersensitivity of 
the SO following the pharmacological stimulus. The clinical value of the diagnosis of 
hyperreactivity of the SO after MS administration is supported by the fact that a sustained 
symptomatic improvement was observed after EST in the patients who gave an exaggerated 
response [83]. However, a subjective complaint such as biliary pain is difficult to assess 
adequately and obviously has a low specificity for SO hyperreactivity when considered alone. 
Therefore, the diagnostic value of these evocative tests is still a matter of debate, since they 
may furnish a certain number of false-positive results and uncertain reproducibility [41]. To 
overcome these problems, it was first suggested, that these tests should be combined with 
estimations of the serum amylase and transaminase levels, since transient rises in the levels of 
these enzymes might be suggestive of a SO spasm [84]. Changes in the plasma levels of liver 
enzymes are clearly related to a MS-induced spasm of the SO, since an AST elevation is not 
observed in patients with an intact GB and is abolished by EST [85]. The combination of the 
Nardi test and hepatobiliary scintigraphy originally suggested by Varró and Csernay has the 
aims of a further improvement of the diagnostic accuracy and visualization of the SO spasm 
[86, 87]. As an improvement of the method originally described, we developed a new 
technique referred to as QHBS combined with prostigmine and morphine provocation, 
whereby the MS-induced SO spasm can be assessed both qualitatively and quantitatively. Our 
results clearly demonstrated that, in a subgroup of patients with suspected SOD, prostigmine 
and MS administration could induce biliary pain and a prolonged spasm of the SO with the 
blockage of the bile flow, revealed by means of QHBS. Furthermore, there was a good 
correlation between the AST rise and the results of QHBS during the Nardi test. QHBS 
combined with the Nardi test can therefore be regarded as an extremely useful method in the 
diagnosis of biliary dyskinesia induced by hyperreactivity of the SO [VI]. By applying this 
method, we were recently able to assess the effectiveness of different drugs on the prevention 
of MS-induced SO spasm in order to explore new therapeutic possibilities in patients with SO 
dyskinesia [XXVIH - XXXI]. 
After the description of the inhibitory and excitatory receptors for CCK on the SO, a 
paradoxical response after CCK administration was suggested as a possible pathogenic 
mechanism of. SO dyskinesia, which would be another obvious manifestation of SO 
hyperreactivity [21]. It was also supposed that cholecystectomy itself alters the neural 
pathways that mediate the inhibitory response of the SO to CCK [88]. Later a paradoxical 
effect of CCK on the SO was demonstrated in 5-16% of patients with suspected SOD by 
means of ESOM [89, 23], It is noteworthy, however, that all of these studies involved the 
administration of a bolus of CCK in relatively high doses (20 to 300 ng/bwkg). This 
paradoxical effect of CCK on the SO might therefore be regarded as a consequence of the 
non-physiological CCK administration. Interestingly, 74% of these patients with 
postcholecystectomy pain syndrome experienced abdominal pain during CCK administration, 
regardless of the manometric findings [23]. A paradoxical response to CCK, i.e. a SO spasm, 
would presumably delay CBD emptying, but in contrast with the manometric findings, no 
such paradoxical effect could be demonstrated in previous scintigraphic studies [90, 91]. To 
investigate this field further, we also administered CCKio during ESOM and QHBS in 
cholecystectomized patients with suspected SO dyskinesia. We found no paradoxical effect of 
CCKio by QHBS. Interestingly, 9 of 20 patients (45%) experienced biliary pain during CCK 
administration that was unrelated to the QHBS results (unpublished data). In contrast, QHBS 
demonstrated that the transpapillary bile flow was highly accelerated in each patient after 
CCKio administration; this was probably induced by a prompt SO relaxation accompanied by 
a simultaneous increase in the hepatic bile secretion [92]. Biliary pain after CCK 
administration might identify a subgroup of patients with SOD and biliary hypersensitivity at 
the time of increased bile secretion and bile flow induced by CCK. Our results confirmed that 
CCKio administration did not increase the sensitivity of QHBS in the diagnosis of SOD, but 
instead diminished the previous bile flow differences [HI]. 
ABP is also a diagnostic problem in patients with an intact GB, since there are no 
morphologic abnormalities and it is difficult to assess the site of the functional abnormality. 
As mentioned above, physiological bile flow variations in these patients with an intact GB 
made the efficacy of QHBS questionable in the diagnosis of SOD. It has recently been 
demonstrated by ESOM that SOD with an elevated SO BP may be present in patients with the 
intact GB, some of them having a well-functioning GB [24, 93]. More importantly, GB and 
SO dyskinesia might occur concomitantly in the same patients, since most of those patients 
with ABP and an elevated SO BP who did not despond to sphincterotomy were cured after 
subsequent cholecystectomy [24]. The lack of a therapeutic response after sphincterotomy, 
but with a symptomatic cure after cholecystectomy, in patients with ABP provides obvious 
indirect evidence in support of the existence of GB dyskinesia [94]. Initially, the diagnosis of 
GB dyskinesia was based upon the reproduction of biliary pain during CCK administration; 
however, this provocation method was also based on the subjective complaints and had a low 
specificity [81]. Therefore, the CCK provocation tests were combined with simultaneous 
determination of the GB EF. With this method, it was demonstrated that a subgroup of 
patients with ABP exhibits an impaired GB emptying with the reproduction of biliary pain 
after CCK administration; and the symptoms in this group of patients their symptoms can be 
alleviated by means of cholecystectomy [95]. However, a low GB EF is obviously not a 
specific sign for the diagnosis of GB dyskinesia, since it may be due to various organic 
disorders, such as chronic cholecystitis, cystic duct obstruction by stone or stricture, etc. [96]. 
It was later proposed that an asymmetric and ineffective contraction of the GB in the 
hepatobiliary scintigram in response to a CCK stimulus may be an important indicator of GB 
dyskinesia [97]. These facts and our previous experience in patients with biliary dyskinesia 
led us recently to develop a new QHBS method, in which CCKio and GTN augmentation 
were combined for the diagnosis of GB dyskinesia. Our results provided the first evidence 
that the NO donor GTN causes a significant improvement in the CCK-induced GB emptying 
in patients with ABP. Normalization of the GB EF in the majority of ABP patients following 
GTN administration strongly suggests that the impairment of GB emptying, frequently 
associated with a biliary pain response after CCK administration, is caused by a functional 
spasm of the cystic duct or the GB neck area, rather than any organic GB disease. In these 
patients, GTN has been shown to abolish biliary pain and to prevent the CCK-induced 
functional spasm of the cystic duct area, with normalization of the GB EF. The influence of 
SO relaxation on this phenomenon may be ignored, in consequence of the fact that, in these 
patients with GB dyskinesia, there was no apparent accumulation of the isotope over the CBD 
when the initial CCK administration was associated with an impaired GB emptying. We have 
also demonstrated a change in the GB shape in the hepatobiliary scintigram due to GTN 
coadministration. The latter phenomenon, termed GB remodelling, strongly supports the 
pathogenic mechanism of GB dyskinesia and may be visual evidence of the functional spasm 
of the cystic duct and the GB neck area. QHBS combined with CCK and GTN 
coadministration may be regarded as a useful method in the diagnosis of GB dyskinesia [II]. 
To summarize our . results, an optimal diagnostic and therapeutic approach may be 
suggested in patients with functional biliary disorders. It is worth mentioning that the 
diagnostic strategy should be modified individually in accord with the clinical status of the 
patient. Consequently, the clinical value and diagnostic role of QHBS must be evaluated in 
relation to the degree of biliary obstruction. ERCP must be performed in all cases when the 
obstruction is a high-grade one, when gallstone disease is suspected by the ultrasound, or 
when AN-augmented QHBS suggests an organic biliary obstruction. If no clinical sign of 
biliary obstruction is evident in a patient with functional biliary pain, it is reasonable to start 
with AN-augmented QHBS to determine bile flow abnormalities. After the exclusion of 
organic causes, the probability of SO dyskinesia or GB dyskinesia is high if a typical clinical 
picture is accompanied by a suggestive QHBS result. The clinician should then decide wheter 
ESOM is indicated to establish the diagnosis. The latter also depends on the therapeutic plan, 
since the QHBS results might not be sufficient to plan an operative endoscopic procedure 
such as EST, which is not without risk. In contrast, if drug therapy is planned, positive 
scintigraphy should be sufficient for the initiation of medical treatment. It is generally 
accepted and proved by long-term follow-up studies that in patients with SO stenosis (SOD of 
biliary group I) EST is the treatment of choice (98-100). As these patients with SOD of biliary 
type I invariably benefit from EST, ESOM is not necessary (100). In contrast, in patients with 
SO dyskinesia (biliary groups II and HI) ESOM is needed to perform in order to prove the 
elevated SO BP as an indication of EST, since in patients with SO dyskinesia and a normal 
SO BP EST did not prove to be more beneficial than the sham procedure (101). Moreover, in 
another follow-up study, a sustained symptomatic improvement was detected after EST in 
only 8% of the patients with SOD of biliary type III (functional group) (102). Therefore, with 
regard to the high incidence of complications following EST in patients with non-dilated 
ducts, it should be considered only after a failure of conservative therapy in the subgroup of 
patients with an elevated SO BP (103). If all these tests are negative, then a provocation test 
may be considered, such as a prostigmine-morphine test combined with QHBS. Provocation 
tests might unmask subtle abnormalities, such as hyperreactivity of the SO, which explain the 
patient's complaints. In patients with ABP, and an intact GB with normal SO motility, QHBS 
combined with CCK and GTN coadministration should be performed to establish the 
diagnosis of GB dyskinesia. 
To summarize the present work, we proved that QHBS is a useful method in the 
diagnosis of functional disorders of the biliary tract. We established a close correlation 
between the bile flow determined by QHBS and the SO pressure measured by ESOM. We 
applied AN and prostigmine-morphine augmentations, QHBS thereby becoming a real 
functional test in the diagnosis of SOD. We combined QHBS with CCK and GIN 
coadministration in patients with intact GB and ABP, which could be a reliable method in the 
diagnosis of GB dyskinesia. We hope that, in the future, these methods will gain general 
acceptance as a first line diagnostic test in patients with suspected biliary dyskinesia. 
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C O N C L U S I O N S A N D N E W FINDINGS 
In asymptomatic cholecystectomized patients, there are only minor patient-to-
patient variations in the dynamics of bile emptying, thereby increasing the 
chance that abnormalities in patients with SOD would be exposed. 
After cholecystectomy, the CBD emptying is accelerated as compared to the 
preoperative status. The parameters of QHBS in cholecystectomized patients and 
in patients with intact GB are therefore ,not comparable. 
QHBS combined with simultaneous CCK10 and GTN coadministration is a useful 
method with which to diagnose GB dyskinesia, and to differentiate this from 
other functional abnormalities of the GB. 
There are significant differences, with only moderate overlaps in the results of 
QHBS when the optimal quantitative parameters (i.e. DAT, HDTT and AR) are 
applied to compare patients suffering from postcholecystectomy pain and 
suspected SOD with asymptomatic cholecystectomized controls. 
Videomanometry of the SO is a promising new method to improve ESOM tracing 
analysis and documentation. It has several advantages over the conventional 
technique, such as an enhancement of the recognition of manometric artefacts 
and the possibility to monitor the catheter position continuously. 
A statistically significant linear correlation was established between the SO BP 
measured by ESOM and the bile flow parameters determined by QHBS in 
patients with suspected SOD. 
HDTT is the most sensitive scintigraphic parameter for detecting an elevated SO 
BP (89%), while the combined sensitivity of Tmaz and Txn of the CBD reached 
72 
100%. Hence, a simple quantification of the CBD TAC during QHBS allows the 
identification of all patients with elevated SO BP on ESOM. 
AN-augmented QHBS is a valuable non-invasive method in the diagnosis of SOD; 
it permits a non-invasive differentiation between organic stenosis and functional 
dyskinesia of the SO. 
QHBS combined with prostigmine-morphine administration is an effective 
method for visualization of the SO spasm at the time of the evoked pain and it 
can therefore be used to improve the diagnostic accuracy of the conventional 
Nardi test. 
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